1. Home
  2. SHO vs HROW Comparison

SHO vs HROW Comparison

Compare SHO & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

SHO

Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

N/A

Current Price

$11.31

Market Cap

2.0B

ML Signal

N/A

HROW

Harrow Inc.

N/A

Current Price

$30.75

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SHO
HROW
Founded
1995
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2004
2008

Fundamental Metrics

Financial Performance
Metric
SHO
HROW
Price
$11.31
$30.75
Analyst Decision
Buy
Strong Buy
Analyst Count
12
9
Target Price
$11.96
★ $65.00
AVG Volume (30 Days)
★ 1.6M
486.5K
Earning Date
11-06-2026
11-09-2026
Dividend Yield
★ 3.21%
N/A
EPS Growth
N/A
★ 71.43
EPS
★ 0.22
N/A
Revenue
★ $1,115,167,000.00
N/A
Revenue This Year
$2.47
$28.81
Revenue Next Year
N/A
$53.97
P/E Ratio
$50.80
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$8.69
$28.54
52 Week High
$12.07
$54.98

Technical Indicators

Market Signals
Indicator
SHO
HROW
Relative Strength Index (RSI) 49.85 27.10
Support Level $10.99 $28.54
Resistance Level $11.19 $35.43
Average True Range (ATR) 0.17 1.25
MACD 0.03 -0.21
Stochastic Oscillator 57.58 11.48

Price Performance

Historical Comparison
SHO
HROW

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in California which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its Hotel Ownership Segment.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: